hit counter
USA Life Sciences Database
Biotechgate Biotechgate Global Database › Global Trial › Global Log-in ›
Life Sciences Database
Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

2024 ASH Oral Presentation----Abbisko presents promising preliminary phase 2 study results of pimicotinib in the treatment of Chronic Graft-versus-Host Disease (cGvHD) at the 66th ASH Annual Meeting

Read more ››
By: PR Newswire Association LLC. - 09 Dec 2024

BRIDGING CLINICAL RESEARCH AND CLINICAL CARE WITH AI-AIDING PATHOLOGISTS TOOL

Read more ››
By: PR Newswire Association LLC. - 09 Dec 2024

AnX Robotica awarded Gastrointestinal Endoscopy Products agreement with Premier, Inc.

Read more ››
By: PR Newswire Association LLC. - 09 Dec 2024

Disc Medicine Presents Positive Updated Results from Phase 1b Trial in Patients with Myelofibrosis (MF) and Anemia in an Oral Presentation at the 66th American Society of Hematology (ASH) Annual Meeting

Read more ››
By: GlobeNewswire - 09 Dec 2024
Related companies:  Disc Medicine, Inc.

Innovent Presents Updated Data From Innovative Anti-CLDN18.2 ADC (IBI343) Phase 1 Study in Patients with Advanced Pancreatic Cancer at the ESMO Asia Congress 2024

Read more ››
By: PR Newswire Association LLC. - 09 Dec 2024
Related companies:  Innovent Biologics (USA), Inc.

AI Tool Fight Health Insurance Goes Viral, Empowering Everyone to Challenge Denied Claims

Read more ››
By: PR Newswire Association LLC. - 09 Dec 2024

DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)-based regimens demonstrate improved rates of minimal residual disease (MRD) negativity and progression-free survival in patients with newly diagnosed multiple myeloma

Read more ››
By: PR Newswire Association LLC. - 09 Dec 2024
Related companies:  Johnson & Johnson, Inc.

Jacobio Pharma Presented preliminary Data on BET Inhibitor for Myelofibrosis at 2024 ASH

Read more ››
By: PR Newswire Association LLC. - 09 Dec 2024
Related companies:  Jacobio Pharmaceuticals

SK Life Science, Inc. Presents XCOPRI® (cenobamate tablets) CV Data at the AES 2024 Annual Meeting Showing a Deeper Understanding of Cenobamate's Dual Mechanism of Action

Read more ››
By: PR Newswire Association LLC. - 08 Dec 2024
Related companies:  SK Life Science, Inc.

AbbVie Announces Emotional Impact Report on Mental Health of Underrepresented CLL Cancer Patients

Read more ››
By: PR Newswire Association LLC. - 08 Dec 2024
Related companies:  AbbVie Inc.

Cogent Biosciences Announces Positive Updated Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)

Read more ››
By: GlobeNewswire - 08 Dec 2024
Related companies:  Cogent Biosciences, Inc.

Longer-term data for Novartis Scemblix® reinforce superior efficacy with favorable safety and tolerability profile in adults with newly diagnosed CML

Read more ››
By: GlobeNewswire - 08 Dec 2024
Related companies:  Novartis AG | Novan, Inc.

C4 Therapeutics Presents Cemsidomide Phase 1 Data at the American Society for Hematology (ASH) Annual Meeting that Demonstrated Potential to Become Best-in-Class IKZF1/3 Degrader

Read more ››
By: GlobeNewswire - 08 Dec 2024
Related companies:  C4 Therapeutics, Inc.

Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivat at ASH 2024 and Provides Regulatory Update on Mitapivat

Read more ››
By: GlobeNewswire - 08 Dec 2024
Related companies:  Agios Pharmaceuticals, Inc.

Studies Highlight Progress in Preventing and Treating Blood Cancers and Pre-Cancerous Conditions

Read more ››
By: PR Newswire Association LLC. - 08 Dec 2024

DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) shows 51 percent reduction in risk of progression to active multiple myeloma for patients with high-risk smoldering multiple myeloma

Read more ››
By: PR Newswire Association LLC. - 08 Dec 2024
Related companies:  Johnson & Johnson, Inc.

Roswell Park Experts Report Insights on CAR T for Follicular Lymphoma, KEYNOTE-667 Combo in Hodgkin Lymphoma

Read more ››
By: PR Newswire Association LLC. - 08 Dec 2024
Related companies:  Roswell Park Comprehensive Cancer Center

TECVAYLI® (teclistamab-cqyv) demonstrates potential as frontline combination therapy for patients with newly diagnosed multiple myeloma

Read more ››
By: PR Newswire Association LLC. - 08 Dec 2024
Related companies:  Johnson & Johnson, Inc.

University of Nebraska Wins the Abbott and Big Ten Conference's Nationwide 'We Give Blood Drive' Competition, Receives $1 Million Grant from Abbott

Read more ››
By: PR Newswire Association LLC. - 08 Dec 2024
Related companies:  Abbott Laboratories

Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ® and Its Impact on Blood Cancer Treatment Decisions

Read more ››
By: GlobeNewswire - 08 Dec 2024
Related companies:  Adaptive Biotechnologies Corporation
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Looking for companies outside of the United States?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

  • December 2024
    • Spectrum of Stem Cell Neuronal Models and Their Purpose Fit
  • January 2025
    • San Francisco: 8th Annual Neuroscience Innovation Forum
    • San Francisco: RESI JPM 2025
See Events »
Add an Event »

Latest company news

University of Nebraska Wins the Abbott and Big Ten Conference's Nationwide 'We Give Blood Drive' Competition, Receives $1 Million Grant from Abbott
08 Dec 2024 (PR Newswire Association LLC.)

Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ® and Its Impact on Blood Cancer Treatment Decisions
08 Dec 2024 (GlobeNewswire)

Novel Combination of Pozelimab and Cemdisiran (Poze-Cemdi) Achieved Greater Control of Intravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Compared to Ravulizumab
08 Dec 2024 (GlobeNewswire)

Biotechgate database

About Biotechgate
The USA Life Sciences Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com